Company File · BSE 532331 · Latest filing Q1 FY27
Standalone = this company only. Consolidated = including its subsidiaries.
Ajanta Pharma Ltd.
Data as of 19 Oct 2026 close · BSE · Latest results Q1 FY27
ISIN INE031B01049 · AJANTPHARM · Healthcare › Pharmaceuticals & Biotechnology
About the business
What does Ajanta Pharma do? It is a Mumbai-based drug maker. What is a branded generic? A copy of an off-patent drug sold under the company's own brand name. Ajanta sells branded generics in India, mainly for heart, eye, skin & pain conditions, & in markets across Asia & Africa. It also sells generic medicines in the US.
Price & valuation · BSE close, 19 Oct 2026
Below its usual level
- Sales growth
- +24.8%
- Profit growth
- +30.9%
- Op. margin
- 26.1%
- P/E
- 36.3×
- Usual P/E
- 36.5×
- Price/book
- 9.11×
- ROCE
- 32.7%
- ROE
- 25.4%
- Debt/equity
- 0.05×
- Promoter
- 63.47%
- Pledged
- 20.65%
The latest earnings call · Apr to Jun 2026 · transcript filed 3 Aug 2026
The transcript is ready to read; its call notes appear here once they are written.
Is it expensive, and is it a good business?
Key ratios
In short Priced below its own usual level (P/E 36.3× vs 36.5×), earns high returns on capital (ROCE 32.7%) and has modest borrowings (debt to equity 0.05×).
What you pay Valuation
Buyers pay about ₹36 for every ₹1 the company earned per share over the last year. Below its 1-year median of 36.5×.
Latest BSE close ÷ last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 19th October 2026.
The share price is 9.1 times the accounting value of each share. Above its 1-year median of 8.5×.
Latest BSE close ÷ book value per share (equity ÷ shares) on the latest balance-sheet date. As of 19th October 2026.
The market values the company at 7.1 times its yearly sales.
Market value ÷ last 12 months' revenue. As of 19th October 2026.
The whole business (shares plus debt, minus cash) is valued at about 28.2 years of its operating profit.
Enterprise value ÷ last 12 months' EBITDA. As of 19th October 2026.
The P/E of 36.3 divided by EPS growth of 14.9% (the latest financial year vs the year before). Below 1 is often read as cheap for the growth; above 2 as expensive.
P/E ÷ 12-month EPS growth in % (the last four quarters vs the four before; when those are not all held, the latest financial year vs the year before). Growth above 100% counts as 100%; left blank when EPS fell or was below ₹1 a share a year earlier. Without one-off items when either year has large ones, as for the P/E. As of 19th October 2026.
The company paid ₹62.00 a share in the last 12 months (3 payouts), 1.88% of today's share price.
Dividends per share with an ex-date in the last 12 months (restated for any split or bonus since) ÷ the latest BSE close. As of 19th October 2026.
How well it uses money Returns & strength
Each ₹100 of shareholders' money and debt earned about ₹32.7 before interest & tax.
Last 12 months' profit before interest & tax ÷ average (equity + borrowings). As of 31st March 2026.
For every ₹100 of shareholders' money, the company earned about ₹25.4 in a year.
Last 12 months' profit after tax (continuing operations where reported) ÷ average equity. As of 31st March 2026.
The money actually tied up in running the business (leaving out spare cash) earned about 25.9% after tax.
Last 12 months' operating profit after tax (profit before interest & tax × (1 − effective tax rate)) ÷ average invested capital (equity + borrowings − cash & bank balances). As of 31st March 2026.
Every ₹1 of assets generated about ₹0.98 of sales in a year.
Last 12 months' revenue ÷ average total assets. As of 31st March 2026.
Operating profit covered interest costs about 107 times.
Last 12 months' profit before interest & tax ÷ finance costs. As of 30th June 2026.
For every ₹1 of shareholders' money, it has borrowed ₹0.05.
Borrowings ÷ shareholders' equity on the latest balance-sheet date. As of 31st March 2026.
Who owns it Ownership & more
The founders or parent group own 63.47% of the company.
Promoter & promoter group shareholding from the latest shareholding pattern filed with BSE. As of 30th September 2026.
Promoter holding fell by 0.01 percentage points last quarter.
Latest quarter's promoter holding minus the previous quarter's. As of 30th September 2026.
Promoter holding, quarter by quarter
- Sep 202663.47%
- Jun 202663.48%
- Mar 202666.25%
- Dec 202566.25%
- Sep 202566.25%
Promoters have pledged 20.65% of their shares (163.8 lakh shares), 13.10% of the company.
Promoter group shares pledged ÷ all the promoter group's shares, from the shareholding pattern filed with BSE each quarter (other encumbrances, such as non-disposal undertakings, are not counted). As of 30th September 2026.
Pledged, quarter by quarter
- Sep 202620.65%
- Jun 202622.53%
- Mar 202617.94%
- Dec 202517.29%
- Sep 202515.28%
After paying for new plant & equipment, operations left ₹164 crore of cash.
Cash from operations − spending on plant & equipment, latest full year. As of 31st March 2026.
Free cash flow, year by year
- FY26₹164 Cr
- FY25₹839 Cr
Each share has a face (nominal) value of ₹2. It matters for dividends quoted as a percentage, not for valuation.
Face value per share as BSE lists it today.
About 12.50 crore shares were in issue.
BSE's count of listed shares (BSE's market cap ÷ its price), so splits, bonuses & new shares since the latest results are included. As of 19th October 2026.
Your ratios
Ratios you added. Your choices are remembered on this device.
The stock market values the company at about ₹41,241 crore.
Latest BSE close × BSE's count of listed shares. As of 19th October 2026.
Buying the whole business, including its debt and keeping its cash, would cost about ₹41,349 crore.
Market value + borrowings − cash & bank balances. As of 19th October 2026.
The company reported ₹1,135 crore of profit over the last four quarters.
Sum of the last four quarters' reported profit after tax. As of 30th June 2026.
Each share earned about ₹90.84 over the last year.
Sum of the last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 30th June 2026.
Each share is backed by about ₹362 of net assets on the books.
Shareholders' equity ÷ shares. As of 31st March 2026.
About ₹25.4 of every ₹100 of sales was left after running costs.
EBITDA ÷ revenue over the last four quarters. As of 30th June 2026.
About ₹20.6 of every ₹100 of sales became profit last quarter.
Profit after tax ÷ revenue for the latest quarter. As of 30th June 2026.
Sales were 24.8% higher than a year earlier.
Latest quarter's revenue vs the same quarter last year. As of 30th June 2026.
Profit was 30.9% higher than a year earlier.
Latest quarter's profit after tax vs the same quarter last year (continuing operations when a one-off discontinued item exists). As of 30th June 2026.
Short-term assets cover short-term bills 2.64 times.
Current assets ÷ current liabilities. As of 31st March 2026.
Customers take about 124 days to pay.
Trade receivables ÷ last 12 months' revenue × 365. As of 31st March 2026.
Stock on hand equals about 63 days of sales.
Inventories ÷ last 12 months' revenue × 365. As of 31st March 2026.
14.5% of pre-tax profit came from other income (interest, dividends, gains).
Other income ÷ profit before tax, last 12 months. As of 30th June 2026.
Each ₹1 of profit brought in ₹0.50 of operating cash.
Latest full year's cash from operations ÷ profit after tax. As of 31st March 2026.
Borrowings exceed cash by ₹107 crore.
Cash & bank balances − borrowings. As of 31st March 2026.
The company paid about 24.0% of its pre-tax profit as tax.
Tax expense ÷ profit before tax (continuing operations), last 12 months. As of 30th June 2026.
Everything the company owns earned 18.9% in a year.
Last 12 months' profit ÷ average total assets. As of 31st March 2026.
Operating profit before interest, depreciation & tax was ₹1,467 crore.
Revenue − expenses + finance costs + depreciation, last four quarters. As of 30th June 2026.
Needs five financial years of cash flows.
Sum over five financial years of (cash from operations − capital expenditure).
The company spent ₹365 crore on plant & equipment.
Purchase of property, plant & equipment, latest full year. As of 31st March 2026.
Borrowings stood at ₹212 crore.
Current + non-current borrowings. As of 31st March 2026.
Foreign institutions own 7.63%.
Foreign institutional holding from the latest shareholding pattern. As of 30th September 2026.
Domestic institutions own 21.94%.
Domestic institutional holding (mutual funds, insurers, banks, pension funds). As of 30th September 2026.
The highest price in the last year was ₹3,796.95.
Highest intraday BSE price in the last 12 months (raw, not adjusted). As of 18th August 2026.
The lowest price in the last year was ₹2,381.5.
Lowest intraday BSE price in the last 12 months (raw, not adjusted). As of 28th October 2025.
The share price moved 35.5% over the last year.
Close today ÷ close a year ago − 1 (raw prices, dividends not included). As of 19th October 2026.
About 68% of the last year's earnings per share was paid out as dividends.
Dividends per share with an ex-date in the last 12 months ÷ the last four quarters' EPS. As of 30th June 2026.
Needs four financial years of results (three years of growth).
Compound annual growth in revenue over three financial years.
Needs four financial years of results (three years of growth).
Compound annual growth in profit after tax over three financial years.
Tap the i beside any ratio for a plain explanation.
How these are worked out
Price-based ratios use the latest BSE close (19th October 2026). Share count 12.50 crore, from paid-up capital in the 19th October 2026 filing. Figures are consolidated.
What you pay: Higher numbers mean you pay more for each rupee the company earns or owns.
How well it uses money: Higher returns mean each rupee in the business earns more. Lower debt means less strain.
Who owns it: A steady promoter stake with nothing pledged is a calm sign.
+ Add your own ratios
Your choices are remembered on this device.
Last 4 quarters ₹ crore · Consolidated
| ₹ crore | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|
| Revenue from operations | 1,354 | 1,375 | 1,422 | 1,626 |
| EBITDA | 327.8 | 382.2 | 333.4 | 423.6 |
| Operating margin | 24.2% | 27.8% | 23.5% | 26.1% |
| Profit after tax | 260.2 | 273.8 | 266.7 | 334.2 |
| Basic EPS (₹) | 20.83 | 21.91 | 21.35 | 26.75 |
Latest filings BSE
Corporate announcements 8
- 6 Oct 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- 1 Oct 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- 30 Sep 2026Submission Of Sustainability Report For FY 2026
Quarterly results 1
- 15 Oct 2026Board Meeting Intimation for Considering And Approving Unaudited Financial Results For Q2 FY 2027
Conference calls 4
- 15 Oct 2026Analyst / Investor Meet - Intimation
- 31 Aug 2026Participation In Investor Conference
- 5 Aug 2026Participation In Investor Conference
Investor presentations 0
None in the filings we hold.
Members see every filing, and what each means for the company in Corporate Intelligence.
The full Company File
- Price, P/E, P/B & returns charts
- Growth vs last year, explained
- Cash from operations vs profit
- Accounts checks
- Who owns it
- 8 quarters, balance sheet & cash flow
- Every BSE filing, in four panels
- Excel & CSV downloads
Education & analysis only, not investment advice or a recommendation.